Summary & Overview
HCPCS C2621: Implantable Pacemaker, Other Than Single or Dual Chamber
HCPCS Level II code C2621 identifies an implantable pacemaker other than single- or dual-chamber devices. These more complex pacemakers are used for patients requiring advanced pacing configurations for cardiac rhythm management and represent a significant component of procedural device care across hospital and ambulatory surgical sites. As implantable cardiac devices, they have implications for hospital surgical services, device inventory management, and post-implant follow-up care.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, the typical sites of service where implants occur, and what payers commonly cover. The publication summarizes reimbursement and billing considerations at a national level, highlights common modifiers associated with device implantation claims, and outlines where to look for policy updates and payer-specific coverage guidance. The document is intended to inform billing, coding, and clinical teams about how C2621 is used in practice, typical claim presentation, and areas where payer policies may affect authorization and payment workflows. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code C2621 denotes an implantable pacemaker other than single or dual chamber. This device is used to provide permanent cardiac pacing for patients with complex rhythm management needs that require more than single- or dual-chamber pacing configurations.
Service type: Implantable cardiac device placement/management
Typical site of service: Inpatient or outpatient hospital setting, ambulatory surgical center, or cardiac specialty clinic
Clinical & Coding Specifications
Clinical Context
A 72-year-old patient with symptomatic complete heart block and a history of syncope is scheduled for implantation of an implantable pacemaker that is neither a single- nor dual-chamber device (for example, a biventricular or leadless system). Pre-procedure evaluation includes device selection by the electrophysiologist, consent, baseline labs (CBC, BMP, coagulation studies), and device programming plan. Typical workflow: pre-op evaluation and device interrogation in clinic; preoperative anesthesia assessment (local with conscious sedation or monitored anesthesia care); implant in a cardiac catheterization laboratory or electrophysiology lab with sterile technique; transvenous or surgical lead placement or device deployment; intraoperative fluoroscopic and electrocardiographic testing to confirm capture, sensing, and lead parameters; device programming and wound closure; post-anesthesia recovery and overnight observation or same-day discharge depending on stability. Follow-up includes device interrogation within 1–2 weeks, wound check, and routine remote monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical due to complexity (document rationale). |
23 |